glp-1 receptor agonist transdermal patch Market Size & Analysis, 2026-2033 Best Berberine Patch for Transdermal

Liraglutide 3.0 mg and intensive behavioral therapy (IBT) for obesity in primary care: the SCALE IBT randomized controlled trial

Whether Medicare covers Ozempic in 2026 depends on why its being prescribed, which Medicare plan youre enrolled in, and the specific formulary your plan uses details that vary significantly across Washington State plans

Tirzepatide: a breakthrough therapy for obstructive sleep apnea and metabolic dysfunction

Lumeng, C

Subscribing to journals, attending conferences, and reviewing clinical guidelines will help integrate new evidence into practice responsibly

*Correspondence: Xian-Feng Zhang, [email protected] These authors have contributed equally to this work and share first authorship This article was submitted to Obesity, a section of the journal Frontiers in Endocrinology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers